切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (06) : 367 -370. doi: 10.3877/cma.j.issn.2095-3232.2014.06.009

所属专题: 文献

临床研究

AFP阳性肝内胆管细胞癌患者的临床特征及其预后影响因素
王庆亮1, 许世磊1, 张鹏1, 黄河1, 姚志成1, 杨培生1, 刘波1,()   
  1. 1. 510530 广州,中山大学附属第三医院普通外科
  • 收稿日期:2014-08-02 出版日期:2014-12-10
  • 通信作者: 刘波
  • 基金资助:
    广东省科技计划项目(2012B31800031)

Clinical characteristics and prognostic factors of intrahepatic cholangiocarcinoma with positive AFP

Qingliang Wang1, Shilei Xu1, Peng Zhang1, He Huang1, Zhicheng Yao1, Peisheng Yang1, Bo Liu1,()   

  1. 1. Department of General Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510530, China
  • Received:2014-08-02 Published:2014-12-10
  • Corresponding author: Bo Liu
  • About author:
    Corresponding author: Liu Bo, Email:
引用本文:

王庆亮, 许世磊, 张鹏, 黄河, 姚志成, 杨培生, 刘波. AFP阳性肝内胆管细胞癌患者的临床特征及其预后影响因素[J]. 中华肝脏外科手术学电子杂志, 2014, 03(06): 367-370.

Qingliang Wang, Shilei Xu, Peng Zhang, He Huang, Zhicheng Yao, Peisheng Yang, Bo Liu. Clinical characteristics and prognostic factors of intrahepatic cholangiocarcinoma with positive AFP[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(06): 367-370.

目的

探讨AFP阳性肝内胆管细胞癌(ICC)患者的临床特点及预后影响因素。

方法

回顾性研究2004年9月至2013年12月在中山大学附属第三医院接受诊治的57例ICC患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。其中男34例,女23例;平均年龄(52±13)岁。根据入院后血清AFP检测结果将患者分为AFP阳性组(16例)和AFP阴性组(41例)。比较两组患者的年龄、性别、HBsAg,合并肝硬化、胆道病变,术前糖链抗原19-9(CA19-9)、手术方式、淋巴结转移、组织学分化程度等临床病理学参数。对患者进行随访,记录两组生存情况。临床病理学参数比较采用t检验、χ2检验或Fisher确切概率法,生存预后影响因素分析采用Log-rank检验和Cox比例风险回归模型多因素分析。

结果

AFP阳性组中男性占94% (15/16),明显高于AFP阴性组的46% (19/41)(χ2=10.747,P<0.05)。AFP阳性组合并肝硬化患者占88% (14/16),明显高于AFP阴性组的37% (15/41) (χ2=11.937,P<0.05)。AFP阳性组患者无合并胆道病变,AFP阴性组12例合并胆道病变,两组比较差异有统计学意义(P<0.05)。手术方式为AFP阳性组患者预后的独立危险因素,根治性切除患者预后好(RR=26.813,P<0.05)。

结论

AFP阳性ICC患者多合并肝硬化,较少合并胆道病变。手术方式为影响患者预后的独立危险因素,根治性切除是改善AFP阳性ICC患者预后的有效手段。

Objective

To investigate the clinical characteristics and prognostic factors in intrahepatic cholangiocarcinoma (ICC) patients with positive alpha-fetoprotein (AFP).

Methods

Clinical data of 57 patients with ICC in the Third Affiliated Hospital of Sun Yat-sen University from September 2004 to December 2013 were analyzed retrospectively. The informed consents of all patients were obtained and the ethical committee approval was received. There were 34 males and 23 females with an average age of (52±13) years old. According to serum AFP test result after admission in hospital, the patients were divided into AFP positive group (n=16) and AFP negative group (n=41). The difference of clinicopathological factors between two groups such as age, gender, hepatitis B surface antigen (HBsAg), liver cirrhosis, biliary lesions, preoperative carbohydrate antigen 19-9 (CA19-9), surgical procedure, metastastic lymph nodes, histological differentiation degree were compared by t-test , Chi-square test or Fisher's exact probability test. The patients were followed up and the survival of two groups was recorded. Prognostic factors analysis was conducted by Log-rank test and Cox proportional hazards regression model.

Results

Male patients accounted for 94% (15/16) in AFP positive group, which was significantly higher than that in AFP negative group [46% (19/41)] (χ2=10.747, P<0.05). Patients complicated with liver cirrhosis accounted for 88% (14/16) , which was significantly higher than that in AFP negative group [37% (15/41)] (χ2=11.937, P<0.05). No patients were complicated with biliary lesions in AFP positive group but in AFP negative group, 12 cases were complicated with biliary lesions, where significant difference was observed between two groups (P<0.05). Surgical procedure was the independent risk factor for patients in AFP positive group. Patients undergoing radical resection had better prognosis (RR=26.813, P<0.05).

Conclusions

ICC patients with positive AFP are mostly complicated with liver cirrhosis but a low incidence of biliary lesions. Surgical procedure is the independent risk factor for the prognosis. Radical resection is an effective way to improve the prognosis of ICC patients with positive AFP.

表1 AFP阳性组与AFP阴性组患者的临床病理学参数的比较(例)
图1 AFP阳性组与AFP阴性组肝内胆管细胞癌患者的Kaplan-Meier生存曲线
[1]
Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma[J]. World J Gastroenterol, 2010, 16(4):418-424.
[2]
Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135(8):1073-1080.
[3]
Zhou H, Wang H, Zhou D, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis[J]. Eur J Cancer, 2010, 46(6):1056-1061.
[4]
Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocarcinoma[J]. Surg Clin North Am, 2010, 90(4):817-837.
[5]
Yamamoto K, Imamura H, Matsuyama Y, et al. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J]. J Gastroenterol, 2010, 45(12):1272-1282.
[6]
Forner A, Reig M, Bruix J. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star[J]. Gastroenterology, 2009, 137(1):26-29.
[7]
Shen WF, Zhong W, Xu F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma[J]. World J Gastroenterol, 2009, 15(47):5976-5982.
[8]
Yamamoto M, Ariizumi S, Otsubo T, et al. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma[J]. J Surg Oncol, 2004, 87(2):80-83, 83-84.
[9]
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma[J]. Hepatology, 2011, 54(1):173-184.
[10]
Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2012, 57(1):69-76.
[11]
Malaguarnera G, Paladina I, Giordano M, et al. Serum markers of intrahepatic cholangiocarcinoma[J]. Dis Markers, 2013, 34(4):219-228.
[12]
Zhou YM, Yang JM, Li B, et al. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein[J]. World J Gastroenterol, 2008, 14(14):2251-2254.
[13]
Witjes CD, Polak WG, Verhoef C, et al. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers[J]. Dig Surg, 2012, 29(6):522-528.
[14]
Gadelhak NA, Gadelhak SA, El-Morsi DA, et al. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma[J]. Hepatogastroenterology, 2009, 56(94/95):1417-1424.
[15]
de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol, 2011, 29(23):3140-3145.
[16]
Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(11):1917-1928.
[17]
Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival[J]. Ann Surg Oncol, 2009, 16(11):3048-3056.
[18]
Li DY, Zhang HB, Yang N, et al. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series[J]. World J Gastroenterol, 2013, 19(47):9084-9091.
[19]
Morine Y, Shimada M, Utsunomiya T, et al. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma[J]. Surg Today, 2012, 42(2):147-151.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[4] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[5] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[6] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[7] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[8] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[9] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[10] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[11] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[12] 秦维, 王丹, 孙玉, 霍玉玲, 祝素平, 郑艳丽, 薛瑞. 血清层粘连蛋白、Ⅳ型胶原蛋白对代偿期肝硬化食管胃静脉曲张出血的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 447-451.
[13] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[14] 朱翔宇, 王建美, 张辉, 叶红英. 无创左心室压力-应变循环技术在左心室功能参数与肝硬化的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 494-498.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要